Patents by Inventor Steve Winitsky

Steve Winitsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal Antibody that Specifically Binds Stem Cells and its Use
    Publication number: 20080095743
    Abstract: Antibodies are disclosed herein that bind Spoc cells. In one embodiment the antibodies are monoclonal antibodies. The use of antibodies that bind Spoc cells to identify and/or isolate a sub-population of Spoc cells is also disclosed. In one embodiment, a method for treating a neurologic disorder is provided. The method includes administering a sub-population of Spoc cells and/or and neuronal cells differentiated from Spoc cells to treat a neurologic disorder.
    Type: Application
    Filed: April 25, 2005
    Publication date: April 24, 2008
    Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS
    Inventors: Neal Epstein, Steve Winitsky, Thiru Gopal, Shahin Hassanzadeh
  • STEM CELLS THAT TRANSFORM TO BEATING CARDIOMYOCYTES
    Publication number: 20070212423
    Abstract: Disclosed herein is a novel isolated population of stem cells, called spoc cells, that can be induced, either in vivo or in vitro, to differentiate into cardiomyocytes. Methods are disclosed herein to differentiate the spoc cells, and to utilize these spoc cells for screening agents that affect cardiomyocytes. Methods are also provided herein to utilize spoc cells in therapeutic applications for the treatment of myocardial defects, such as areas of ischemic or traumatic damage.
    Type: Application
    Filed: May 10, 2007
    Publication date: September 13, 2007
    Inventors: Neal Epstein, Thiru Gopal, Steve Winitsky, Shahin Hassanzadeh
  • Stem cells that transform to beating cardiomyocytes
    Publication number: 20050058633
    Abstract: Disclosed herein is a novel isolated population of stem cells, called spoc cells, that can be induced, either in vivo or in vitro, to differentiate into cardiomyocytes. Methods are disclosed herein to differentiate the spoc cells, and to utilize these spoc cells for screening agents that affect cardiomyocytes. Methods are also provided herein to utilize spoc cells in therapeutic applications for the treatment of myocardial defects, such as areas of ischemic or traumatic damage.
    Type: Application
    Filed: June 7, 2004
    Publication date: March 17, 2005
    Inventors: Neal Epstein, Thiru Gopal, Steve Winitsky, Shahin Hassanzadeh